Enhancement of Osteogenic Differentiation by Combination Treatment with 5-azacytidine and Thyroid-Stimulating Hormone in Human Osteoblast Cells
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Objectives: The role of thyroid-stimulating hormone (TSH) signaling on osteoblastic differentiation is still undetermined. The aim of this study was to investigate the effects of 5-aza-2'-deoxycytidine (5-azacytidine) on TSH-mediated regulations of osteoblasts. Materials and Methods: MG63, a human osteoblastic cell-line, was treated with 5-azacytidine before inducing osteogenic differentiation using osteogenic medium (OM) containing L-ascorbic acid and β-glyceophosphate. Bovine TSH or monoclonal TSH receptor stimulating antibody (TSAb) was treated. Quantitative real-time PCR analyses or measurement of alkaline phosphatase activities were performed for evaluating osteoblastic differentiation. Results: Studies for osteogenic-related genes or alkaline phosphatase activity demonstrated that treatment of TSH or TSAb alone had no effects on osteoblastic differentiation in MG63 cells. However, treatment of 5-azacytidine, per se, significantly increased osteoblastic differentiation and combination treatment of 5-azacytidine and TSH or TSAb in the condition of OM showed further significant increase of osteoblastic differentiation. Conclusion: Stimulating TSH signaling has little effects on osteoblastic differentiation in vitro. However, in the condition of epigenetic modification using inhibitor of DNA methylation, TSH signaling positively affects osteoblastic differentiation in human osteoblasts.
Abstract
Background and Objectives: The role of thyroid-stimulating hormone (TSH) signaling on osteoblastic differentiation is still undetermined. The aim of this study was to investigate the effects of 5-aza-2'-deoxycytidine (5-azacytidine) on TSH-mediated regulations of osteoblasts. Materials and Methods: MG63, a human osteoblastic cell-line, was treated with 5-azacytidine before inducing osteogenic differentiation using osteogenic medium (OM) containing L-ascorbic acid and β-glyceophosphate. Bovine TSH or monoclonal TSH receptor stimulating antibody (TSAb) was treated. Quantitative real-time PCR analyses or measurement of alkaline phosphatase activities were performed for evaluating osteoblastic differentiation. Results: Studies for osteogenic-related genes or alkaline phosphatase activity demonstrated that treatment of TSH or TSAb alone had no effects on osteoblastic differentiation in MG63 cells. However, treatment of 5-azacytidine, per se, significantly increased osteoblastic differentiation and combination treatment of 5-azacytidine and TSH or TSAb in the condition of OM showed further significant increase of osteoblastic differentiation. Conclusion: Stimulating TSH signaling has little effects on osteoblastic differentiation in vitro. However, in the condition of epigenetic modification using inhibitor of DNA methylation, TSH signaling positively affects osteoblastic differentiation in human osteoblasts.
참고문헌 (18)
- Bassett JH, "The molecular actions of thyroid hormone in bone", Trends Endocrinol Metab, 14(8), pp.356~364 (2003)
- Blum MR, "Subclinical thyroid dysfunction and fracture risk: a meta-analysis", JAMA, 313(20), pp.2055~2065 (2015)
- Murphy E, "Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women", J Clin Endocrinol Metab, 95(7), pp.3173~3181 (2010)
- Sun L, "TSH and bone loss", Ann N Y Acad Sci, 1068, pp.309~318 (2006)
- Abe E, "TSH is a negative regulator of skeletal remodeling", Cell, 115(2), pp.151~162 (2003)
- Tuncel M, "The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake", Cancer Biother Radiopharm, 22(3), pp.443~449 (2007)
- Schmittgen TD, "Analyzing real-time PCR data by the comparative C(T) method", Nat Protoc, 3(6), pp.1101~1108 (2008)
- Baran DT, "Thyroid hormone and bone mass: the clinician's dilemma", Thyroid, 4(2), pp.143~144 (1994)
- Liu XS, "Quantification of the roles of trabecular microarchitecture and trabecular type in determining the elastic modulus of human trabecular bone", J Bone Miner Res, 21(10), pp.1608~1617 (2006)
- Hase H, "TNFalpha mediates the skeletal effects of thyroid-stimulating hormone", Proc Natl Acad Sci U S A, 103(34), pp.12849~12854 (2006)
- Sun L, "Genetic confirmation for a central role for TNFalpha in the direct action of thyroid stimulating hormone on the skeleton", Proc Natl Acad Sci U S A, 110(24), pp.9891~9896 (2013)
- Baliram R, "Thyroid-stimulating hormone induces a Wnt-dependent, feed-forward loop for osteoblastogenesis in embryonic stem cell cultures", Proc Natl Acad Sci U S A, 108(39), pp.16277~16282 (2011)
- Sampath TK, "Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats", J Bone Miner Res, 22(6), pp.849~859 (2007)
- Sun L, "Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss", Proc Natl Acad Sci U S A, 105(11), pp.4289~4294 (2008)
- Cho SW, "The presence of thyroid-stimulation blocking antibody prevents high bone turnover in untreated premenopausal patients with Graves' disease.", PLoS One, 10(12), pp.e0144599~ (2015)
- de Andres MC, "Epigenetic regulation during fetal femur development: DNA methylation matters", PLoS One, 8(1), pp.e54957~ (2013)
- Villagra A, "Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts", J Cell Biochem, 85(1), pp.112~122 (2002)
- Dong Sun Kim, "Methylation of the Mouse DIx5 and Osx Gene Promoters Regulates Cell Type-specific Gene Expression", Molecules and Cells, 22(2), pp.182~188 (2006), 한국분자세포생물학회